Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Grant Connelly Insider Profile
4 Followers
Grant Connelly, Chief Executive Officer at Neupath Health Inc., holds 160.25K shares in Neupath Health Inc. (Ticker: TSE:NPTH).
Grant Connelly Neupath Health Inc. (NPTH)Chief Executive Officer
Neupath Health Inc. (NPTH)
Chief Executive Officer
Ranked #76,977 out of 99,024 Corporate Insiders
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-36.50%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chief Executive Officer
Roles that Grant Connelly holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Sep 15, 2020 - Sep 15, 2021
Return:-35.20%
The most profitable trade made by Grant Connelly
Grant Connelly's Trading History
List of latest transactions for each holding click on a transaction to see Grant Connelly's performance on stock
You May Also Like
Grant Connelly insider profile FAQ
What is the percentage of profitable transactions made by Grant Connelly?
The percentage of profitable transactions made by Grant Connelly is 0%.
What is the average return per transaction made by Grant Connelly?
The average return per transaction made by Grant Connelly is -36.50%.
What stocks does Grant Connelly hold?
Grant Connelly holds: TSE:NPTH stocks.
What was Grant Connelly’s latest transaction?
Grant Connelly latest transaction was an Uninformative Sell of C$8.41K.
What was Grant Connelly's most profitable transaction?
Grant Connelly’s most profitable transaction was an Informative Buy of TSE:NPTH stock on September 15, 2020. The return on the trade was -35.20%.
What is Grant Connelly's role in Neupath Health Inc.?
Grant Connelly's role in Neupath Health Inc. is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.